Hypertension is a chronic non communicable disease and often asymptomatic medical condition in which the pressure exerted by the blood on the wall of the artery is elevated. It is chiefly of unknown aetiology, but genetic factors play significant role for its development. Uncontrolled hypertension is a risk factor for various pathological conditions such as heart attack, heart failure, stroke, retinal haemorrhage and kidney disease. In Ayurveda a number of medicinal plants and Ayurveda compound formulations have been prescribed by Ayurveda doctors for the treatment of hypertension. The therapeutic efficacy of those plants has also being verified by using modern pharmacological experimental models. This paper reviews various clinical and experimental studies conducted in the last few decades on plants showing anti-hypertensive property.
Introduction: Beyond infection, the COVID-19 pandemic has also affected individuals through associated mental illnesses like anxiety and stress and has caused a collateral damage. Ayurveda has described 3 main factors which are responsible for the occurrence of diseases, one of them is Prajnaparadha, which is stated as the main cause for all the mental illness. The threefold treatment principles of Daivavyapashraya, Yuktivyapashraya and Satvavajaya targeting the Ahara, Achara and Chesta is an ideal plan to deal with stress built up in this pandemic.
Materials and methods: The Ayurvedic classical textbooks and the peer reviewed articles focusing mental health researches were reviewed. This plan involves the implementation of Daivavyapashraya, Yuktivyapashaya and Satvavajaya based on the exposure and exhibition of symptoms of COVID-19. Daivavyapashraya Chikitsa is employed by Vishnusahasranama recitation/listening, Yuktivyapashraya Chikitsa is employed by the various drugs like Bramhi, Shankapushpi, Ashwagandha etc. and formulations which have psycho-neuro-immune-response, Satvavajaya Chikitsa by the process of counseling.
Results and Discussion: The interdependent nature of immunity and psychological state is already well established and it decides the outcome of disorders. An immune response can be largely affected by mental well-being and mental illness can negatively affect its outcome.
Conclusion: The three fold treatment plan centering the pshycho-neuro-immune action is a complete health promotive, preventive and curative plan and will certainly help in the revival of mental health in the times and after the COVID-19 pandemic.
Diabetes is a clinical condition characterized by a spike in blood glucose in plasma. It is one of the 21st century's greatest public health crises and is among the top 10 causes of death worldwide. Although new drugs and therapeutics are emerging for its management but the prevalence is increasing at an alarming pace; thus, every system must contribute for effective management. An effort is made to review the efficacy and safety evaluation of the individual herbs of Darvyadi Kwatha (DK), an Ayurvedic formulation mentioned in Charaka Samhita. The constituents of the DK has some strong efficient antidiabetic/hypoglycaemic chemical principle having insulin-triggering and insulin-like behaviors which increases the activity of glucose-6-phosphate dehydrogenase (G6PD) and glucokinase and decreases glucose-6-phosphatase activity, reduce oxidative stress and prevention of glutathione reductase, superoxide dismutase, and catalase activity play a critical role in glucose homeostasis. DK also improve biochemical parameters such as SGPT, SGOT, cholesterol and triglycerides and is found to be safe in animal experiments. The various evidences clearly indicates that DK has definite hypoglycemic potential as well as anti-diabetic activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.